Roberta Ottria (R Ottria)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Molecules (Basel, Switzerland)

International journal of molecular sciences

Cancers

Scientific reports

University of Milan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Milan Oct 1o 2017 - Feb 1o 2023

Italy

Ricercatori

Publications

Roberta Ottria, Ornella Xynomilakis, Silvana Casati, Ezio Abbiati, Giovanni Maconi, Pierangela Ciuffreda
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future. International journal of molecular sciences 24 (15) (2023)
Paolo La Rocca, Alessandra Mingione, Silvana Casati, Roberta Ottria, Pietro Allevi, Pierangela Ciuffreda, Paola Rota
Small-Molecules as Chemiluminescent Probes to Detect Lipase Activity. International journal of molecular sciences 23 (16) (2022)
Roberta Ottria, Silvana Casati, Paola Rota, Pierangela Ciuffreda
2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization. Molecules (Basel, Switzerland) 27 (16) (2022)
Matteo Miceli, Silvana Casati, Pietro Allevi, Silvia Berra, Roberta Ottria, Paola Rota, Bruce R Branchini, Pierangela Ciuffreda
A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase. International journal of molecular sciences 22 (11) (2021)
Silvana Casati, Paola Rota, Pietro Allevi, Alessandra Mingione, Roberta Ottria, Pierangela Ciuffreda
Clarifying the Use of Benzylidene Protecting Group for D-(+)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C-Nucleosides. Molecules (Basel, Switzerland) 26 (21) (2021)
Francesco Andreata, A Bonizzi, M Sevieri, M Truffi, M Monieri, L Sitia, F Silva, L Sorrentino, R Allevi, P Zerbi, B Marchini, E Longhi, Roberta Ottria, Sara Casati, Renzo Vanna, C Morasso, M Bellini, D Prosperi, F Corsi, S Mazzucchelli
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Scientific reports 10 (1) (2020)
Riccardo Vago, Alessandro Ravelli, Arianna Bettiga, Silvana Casati, Giovanni Lavorgna, Fabio Benigni, Alessia d'Arma, Francesco Montorsi, Marica Orioli, Pierangela Ciuffreda, Roberta Ottria
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage. Cancers 12 (4) (2020)
Silvana Casati, Roberta Ottria, Pierangela Ciuffreda
Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods. Molecules (Basel, Switzerland) 25 (9) (2020)
Sara Casati, Chiara Giannasi, Mauro Minoli, Stefania Niada, Alessandro Ravelli, Ilaria Angeli, Veronica Mergenthaler, Roberta Ottria, Pierangela Ciuffreda, Marica Orioli, Anna Teresa Brini
Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by UHPLC-MS/MS. Biomolecules 10 (9) (2020)
Matteo Miceli, Silvana Casati, Roberta Ottria, Simone Di Leo, Ivano Eberini, Luca Palazzolo, Chiara Parravicini, Pierangela Ciuffreda
Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe. Molecules (Basel, Switzerland) 24 (12) (2019)
Roberta Ottria, Alessandro Ravelli, Matteo Miceli, Sara Casati, Marica Orioli, Pierangela Ciuffreda
Correction: Ottria, R., et al. Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS. Molecules 2019, 24, 989. Molecules (Basel, Switzerland) 24 (9) (2019)
Roberta Ottria, Alessandro Ravelli, Matteo Miceli, Sara Casati, Marica Orioli, Pierangela Ciuffreda
Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS. Molecules (Basel, Switzerland) 24 (5) (2019)
Arianna Bonizzi, Marta Truffi, Marta Sevieri, Raffaele Allevi, Leopoldo Sitia, Roberta Ottria, Luca Sorrentino, Cristina Sottani, Sara Negri, Elena Grignani, Serena Mazzucchelli, Fabio Corsi
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines. Pharmaceutics 11 (8) (2019)

Roberta Ottria.css-eqlu8i{font-size:small;padding-left:4px;} (R Ottria)

Publication Activity (10 Years)

Top Topics

Top Venues

Roberta Ottria (R Ottria)